Results 101 to 110 of about 3,808 (176)

Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators. [PDF]

open access: yesCancer Discov
Fece de la Cruz F   +28 more
europepmc   +1 more source

Real-world characterization of patients with advanced or metastatic liposarcoma, including dedifferentiated liposarcoma, in Japan in the MASTER KEY project. [PDF]

open access: yesJpn J Clin Oncol
Okuma HS   +13 more
europepmc   +1 more source

Tumor size as a key determinant of treatment strategy and prognosis in stereotactic body radiotherapy for pulmonary metastases: a retrospective study. [PDF]

open access: yesRep Pract Oncol Radiother
Okuma K   +10 more
europepmc   +1 more source

Intentional internal high-dose policy in VMAT for stage III NSCLC with consolidation durvalumab - a retrospective study. [PDF]

open access: yesRep Pract Oncol Radiother
Okuma K   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy